Opinion

Kavanagh: It’s time to reform drug pricing rules in the U.S.

Posted 6/24/22

As we get closer to election season, we are going to hear a lot more about the issues that seemingly always come up around this time of year.

This story requires a subscription for $5.99/month.

Already have an account? Log in to continue.

Current print subscribers can create a free account by clicking here.

Otherwise, click here to subscribe.

To Our Valued Readers –

Visitors to our website will be limited to five stories per month unless they opt to subscribe. The five stories do not include our exclusive content written by our journalists.

For $5.99, less than 20 cents a day, digital subscribers will receive unlimited access to YourValley.net, including exclusive content from our newsroom and access to our Daily Independent e-edition.

Our commitment to balanced, fair reporting and local coverage provides insight and perspective not found anywhere else.

Your financial commitment will help to preserve the kind of honest journalism produced by our reporters and editors. We trust you agree that independent journalism is an essential component of our democracy. Please click here to subscribe.

Sincerely,
Charlene Bisson, Publisher, Independent Newsmedia

Please log in to continue

Log in

Subscribe to our e-newsletter for continued access

Free newsletter subscribers to the Daily Independent can enjoy free access to our AP stories, Capital Media Services, earned media and special contributors on our Opinions with Civility pages. If you aren’t a free newsletter subscriber yet, join now and continue accessing more content. This does not include our exclusive content written by the newsroom. We hope you’ll consider supporting our journalism.

I am anchor
Opinion

Kavanagh: It’s time to reform drug pricing rules in the U.S.

Posted

As we get closer to election season, we are going to hear a lot more about the issues that seemingly always come up around this time of year.

Specifically, drug prices are going to be a major talking point.

While it may feel like no progress is getting done on the issue, it appears that the leaders of both parties are starting to recognize that a major driver of high drug prices are in fact the pharmacy benefit managers. These middlemen have played a large role in raising the prices of prescription medication through shady tactics like not passing drug manufacturer coupons through to the consumer.

Luckily, Senate leaders on both sides of the aisle have introduced legislation that calls for the investigation of these pharmacy benefit managers or have been outspoken about the needed reform. Arizona leaders like Sens. Kyrsten Sinema and Mark Kelly are going to be key to get action on this issue, and now is the time to do it.

Comments

No comments on this item Please log in to comment by clicking here